KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Eli Lilly (LLY) Liabilities from Discontinued Operations (2018)

Eli Lilly's Liabilities from Discontinued Operations history spans 1 years, with the latest figure at 692800000.0 for Q4 2018.

For Q4 2018, Liabilities from Discontinued Operations changed N/A year-over-year to 692800000.0; the TTM value through Dec 2018 reached 692800000.0, changed N/A, while the annual FY2018 figure was 692800000.0, N/A changed from the prior year.
Liabilities from Discontinued Operations reached 692800000.0 in Q4 2018 per LLY's latest filing.
In the past five years, Liabilities from Discontinued Operations ranged from a high of 692800000.0 in Q4 2018 to a low of 692800000.0 in Q4 2018.